Lau, Alaster H Y <br/><br/>
Prostacyclin receptor-dependent inhibition of human erythroleukemia cell differentiation is STAT3-dependent.  [electronic resource] 

 -  Prostaglandins, leukotrienes, and essential fatty acids  Mar 2012 
 - 119-26 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1532-2823 
<br/><br/><label>Standard No.: </label>10.1016/j.plefa.2011.12.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cell Differentiation<br/>Cell Line, Tumor<br/>Cell Survival<br/>Epoprostenol--analogs & derivatives<br/>Humans<br/>Integrin beta3--metabolism<br/>Leukemia, Erythroblastic, Acute--metabolism<br/>Platelet Membrane Glycoprotein IIb--metabolism<br/>Receptors, Epoprostenol--metabolism<br/>STAT3 Transcription Factor--metabolism<br/>Signal Transduction<br/>Tetradecanoylphorbol Acetate--pharmacology